Vioxx, Rofecoxib News

The Obama administration sided with investors Monday in a U.S. Supreme Court case that examines whether shareholders of Merck & Co.

When Richard Clark was named CEO and president of Merck in 2005, the drug behemoth was reeling in the wake of the Vioxx scandal, which in 2004 forced the company to withdraw the blockbuster painkiller for safety reasons.

Merck & Co. lost a bid in the Canadian Supreme Court to put a Vioxx lawsuit on hold in Ontario, while it won a ruling that prevents another case from moving forward as a class action in Saskatchewan.

Peter Lurie, former director of the health research group at Washington, DC-based watchdog group Public Citizen, will be serving in the Office of Policy helping to "develop strategies to facilitate medical product availability to meet critical public health needs," Peter Pitts, president of the Center for Medicine in the Public Interest and former ...

Merck & Co. paid doctors and nurses a total of $3.7 million this summer to give talks to colleagues about the drugmaker's products and other health topics, Merck disclosed Monday.

Reflecting another strong year of major trial wins, multi-million dollar settlements and key leadership appointments in a variety of complex litigation matters, the firm of Seeger Weiss LLP has once again been named to the National Law Journal's Plaintiffs Hot List.

The health community seems to be watching some fireworks this years- big merger, layoffs, patent expiration.

Questions about securities fraud, Sarbanes-Oxley, financial executives' compensation and football merchandise are among the high-profile cases that the Supreme Court will take up in its term that began this week: Vioxx suits: Merck & Co.

Federal health advisers voted 6-4 on Monday that the potential benefits of a Schering-Plough drug outweigh its toxic risks as a treatment for late-stage skin cancer.

In the national debate on health reform, there is plenty of rhetoric about rationing medicine but little constructive talk about practicing "rational medicine," said Dr.

Five years after the high-profile withdrawal of Merck & Co's arthritis drug Vioxx from the market, French pharmaceutical company NicOx is trying to wow the regulators with its first-in-class anti-inflammatory drug naproxcinod.

The Food and Drug Administration is laying out plans to improve its public communications on food and drug safety, more than three years after federal advisers recommended major changes.

For many months, advocates of health care reform have implored President Obama to outline in greater detail the provisions he's prepared to push and defend.

Merck employees had "hit list" of doctors they sought to "neutralize", court documents reveal >> Posted By onlyonesecret 17 hours, 32 minutes ago in News Previously secret documents that surfaced at a Vioxx court case in April of this year reveal pharmaceutical giant Merck maintained a "hit list" of doctors to be "neutralized" for speaking out ...

Previously secret documents that surfaced at a Vioxx court case in April of this year reveal pharmaceutical giant Merck maintained a "hit list" of doctors to be "neutralized" for speaking out against Vioxx.

The Food and Drug Administration has taken the unprecedented step of acknowledging that it buckled to "extreme" pressure from Capitol Hill in its approval of a knee repair device last year.

Merck & Co. is paying claims by the families of more than 3,100 users of its Vioxx painkiller who died of heart attacks or strokes blamed on the drug, according to a law firm administering a $4.85 billion settlement fund.

Defense lawyers in the drug case surrounding the death of Anna Nicole Smith have been notified that prosecutors will file an amended complaint at a discovery hearing.

I have received and been trained in various alternative therapies including receiving acupuncture treatments, using herbal supplements, and providing various energy treatments to others.

The US government says no. And, she said with dripping sarcasm, they have such a great track record with getting this sort of information right.